Dexmedetomidine Wound Infiltration in Cesarean Section

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Postoperative Pain

In brief

The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).

Key facts

Study ID

NCT03382938

Run by

Attikon Hospital

People needed

100

Starts

2019-08-23

Expected to finish

2026-11-20

Last updated by the study team

2025-03-19

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• pregnancy >37 weeks, ASA I-II, BMI<35

You may not qualify if…

• patient refusal, epilepsy, GERD, morbid obesity, drug allergy, ASA class >2, presence of atrioventricular block, severe systemic disease, multiple gestation, high risk pregnancy, contraindications to epidural technique, a history of severe systemic disease, recreational drug or alcohol use

Where it is running

• Paraskevi K Matsota — Athens, Other, Greece (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.